Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Key Stock Data
The current last sale of $38.01 is 13.46% Higher than the 52 week low.
|Intraday||Last 52 Weeks|
|High:||$ 38.57||$ 111.36|
|Low:||$ 36.34||$ 33.50|
ETFs with NKTR as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|7.92%||Virtus LifeSci Biotech Products ETF (BBP)||-6.76 (-15.68%)|
|*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past 100 days.|
Company Description (as filed with the SEC)
Nektar Therapeutics is a research-based biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our research and development pipeline of new investigational drugs includes treatments for cancer, autoimmune disease and chronic pain. We leverage our proprietary and proven chemistry platform to discover and design new drug candidates. These drug candidates utilize our advanced polymer conjugate technology platforms, which are designed to enable the development of new molecular entities that target known mechanisms of action. We refer to our drug candidates where we retain at least U.S. commercial rights as "proprietary programs" and our other drug candidate programs that we have licensed U.S. and potentially other commercial rights to collaboration partners as "collaboration partner programs. ... More ...
Nasdaq Official Price
Nov. 19, 2018
Nov. 19, 2018